Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Classification of primary cutaneous large cell lymphomas

R Willemze1, R C Beljaards, U Rijlaarsdam

  • 1Department of Dermatology, Free University Hospital, Amsterdam, The Netherlands.

Dermatologic Clinics
|April 1, 1994
PubMed
Summary

Primary cutaneous lymphomas are diverse. CD30-positive T-cell lymphomas have a good prognosis, while CD30-negative types often indicate a poor outlook, requiring further research.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia.

Leukemia·2009
Same author

Survey among patients with basal cell carcinoma in The Netherlands.

The Journal of dermatological treatment·2009
Same author

Reduced IL-1Ra/IL-1 ratio in ultraviolet B-exposed skin of patients with polymorphic light eruption.

Experimental dermatology·2008
Same author

Bone marrow examination has limited value in the staging of patients with an anaplastic large cell lymphoma first presenting in the skin. Retrospective analysis of 107 patients.

The British journal of dermatology·2008
Same author

Profiling of apoptosis genes identifies distinct types of primary cutaneous large B cell lymphoma.

The Journal of pathology·2008
Same author

Leiden reconstructed human epidermal model as a tool for the evaluation of the skin corrosion and irritation potential according to the ECVAM guidelines.

Toxicology in vitro : an international journal published in association with BIBRA·2008

Area of Science:

  • Dermatology
  • Hematology
  • Oncology

Background:

  • Primary cutaneous lymphomas (PCL) are a varied group of T- and B-cell malignancies.
  • Recent research has identified distinct clinicopathologic entities within PCL.
  • Primary cutaneous follicular lymphomas are the most frequent B-cell type, typically presenting indolently with a favorable prognosis.

Purpose of the Study:

  • To differentiate between CD30-positive and CD30-negative primary cutaneous T-cell lymphomas (T-LCL).
  • To clarify the prognostic implications of CD30 expression in T-LCL.
  • To highlight the need for further investigation into CD30-negative T-LCL subgroups.

Main Methods:

  • Clinicopathologic analysis of primary cutaneous large cell lymphomas.
  • Immunohistochemical assessment for CD30 expression on T-LCL.
  • Review of clinical presentation, treatment response, and patient outcomes.

Main Results:

  • Primary cutaneous CD30-positive T-LCL, including anaplastic and non-anaplastic subtypes, represent a distinct entity with a favorable prognosis.
  • These CD30-positive T-LCLs may share features with lymphomatoid papulosis, suggesting a spectrum of CD30-positive lymphoproliferative disorders.
  • Primary CD30-negative T-LCL are generally associated with a poor prognosis (4-year survival < 25%).

Conclusions:

  • CD30 expression is a critical factor in determining the prognosis of primary cutaneous T-cell lymphomas.
  • Primary cutaneous CD30-positive T-LCL have a favorable outlook.
  • Further research is essential to define prognostic subgroups within the heterogeneous category of primary CD30-negative T-LCL.

Related Experiment Videos